Please login to the form below
Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021
The Innovative Trials' Equality & Diversity (E&D) committee made a pledge for 2021 to raise awareness around different therapeutic areas and events related to diverse populations. In the December blog, the E&D committee summarises the hot topics discussed during 2021.
Read the blog here
Company Details
Innovative Trials
+44 (0) 1707 378 581
Address:
Innovative Trials Ltd, Innovative House
Avenue One
Letchworth Garden City
Hertfordshire
SG6 2WW
United Kingdom
Latest content on this profile
- Kate Shaw comments the appointment of an independent review on clinical trials in the UK.
- The news comes after a report by the Association of the British Pharmaceutical Industry (ABPI) highlighted a 44% decline in industry clinical trials in the UK over the last five years.
Innovative Trials
- Patient Recruitment: Think Global, Act Local
- Global clinical trials are a vital component of pharma R&D. Utilizing sites in multiple countries not only provides increased access to eligible and diverse patients - and therefore more robust data - but also promotes health equity and research and innovation across continents.Another benefit of global clinical trials is the potential for these studies to be completed more quickly and efficiently [1]. However, around four in five clinical trials fail to meet their patient recruitment deadlines [2], which delays patient access to innovative new therapeutics and can prove costly to Sponsors.Just as treatments are becoming more personalized, so should clinical trial patient recruitment strategies. A ‘one size fits all’ approach to enrollment fails to consider how factors such as an individual country’s culture, healthcare structure and patients’ needs can affect a site’s ability to recruit eligible participants. The key to patient enrollment success is to ‘think local’, even for global studies.In this webinar, we will:Discuss the benefits of using a diversified patient recruitment approach for each country within a global studyInvestigate how patient recruitment strategies can differ from country to country,Hear from two in-country patient recruitment specialists about the challenges relevant to their regions and how they work with sites to overcome theseShare how Innovative Trials’ ‘boots-on-the-ground’ approach in more than 70 countries around the world can help accelerate patient recruitment and retention for your clinical trials.SpeakersGeorgia Hardy - Site Operations Lead, Innovative TrialsNicole Yingst - Associate Director, Patient Recruitment Programs, PfizerBarbara OrlosKaminska - Clinical Enrollment Manager (Poland), Innovative Trials
Innovative Trials
- Innovative Trials comments on extra funding to increase access to clinical trials for cancer patients
- Kate Shaw, Innovative Trials' Founder & CEM, reflects on the exciting news for patients affected by cancer in the UK.
Innovative Trials
- Kate Shaw reflects on Innovative Trials' first US office openings
- On Thanksgiving, Kate Shaw, Founder and CEO of Innovative Trials, reflects on the company first US office opening
Innovative Trials
- Innovative Trials on the latest ABPI report
- Kate Shaw, Innovative Trials Founder & CEO, commented on the latest ABPI report
Innovative Trials
- Innovative Trials featuring in a Clinical Trials Arena article
- Leanne Keem, Head of Operations and Client Relationship at Innovative Trials, featured in a recent article.
Innovative Trials
